REC reference: TBC 

ISCRTN: TBC

Clinical Trials Unit: Nottingham Clinical Trials Unit 

Sponsor: University Hospitals of Derby and Burton NHS Foundation Trust 

Funder: National Institute for Health Research (NIHR) 

Recruitment Target: 240 

Overall Trial End Date:  30 April 2030

To express an interest for your hospital to take part, click below:

DEXTA Expression of Interest Form

DEXTA logo for content card small

 

Study Resources 

DEXTA Protocol

DEXTA Patient Facing Documents

 

 

 

Training Materials

REDCap Training Videos
REDCap Training Videos
 

 

API Scheme

DEXTA aims to register for NIHR Associate Principle Investigator Scheme 

 

Click here to read more about the API scheme

DEXTA aims to register for NIHR Associate Principle Investigator Scheme upon receiving regulatory approval.

Please identify trainees who would be interested in enrolling. Upon successful registeration, applicants will be able to register to be an Associate PI for DEXTA, having obtained approval from their local PI.

To register, please visit Apply to be Associate Principal Investigator and please inform the DEXTA team before submitting a registration form. 

For DEXTA PI’s this could have the benefit of providing additional support in delivering the study, whilst allowing trainees to incorporate research into their training. The scheme is open to trainees, nurses, and allied health professionals, allowing them to gain official recognition for research activity (it is not open to those whose roles are already research funded). The scheme allows others to work alongside the PI, however the PI always retains oversight of the trial.

Involves: A 6-month commitment to the trial is required to gain associate PI status, and NIHR provide a checklist of tasks to be completed during those 6 months. These activities are all logged on the NIHR learn platform. Upon completion of the scheme, you will receive a certificate. We would love to share this news on our site newsletters and our 'X' account @DEXTA_NCTU if you consent to us sharing this.

 

 

 

 

Site News

Site news
Site news